GemPharmatech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 688046?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	2,562,872	0.627%
General Public	35,329,862	8.65%
Institutions	119,274,285	29.2%
Private Companies	251,311,006	61.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 89.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
49.4%	Nanjing Laoyan Venture Capital Partnership Enterprise (Limited Partnership)	201,817,185	CN¥2.7b	0%	no data
4.98%	Sinopharm Junbai (Tianjin) Equity Investment Management Co., Ltd.	20,340,000	CN¥275.2m	-0.78%	no data
3.18%	Jiangsu Industrial Technology Research Institute	12,988,621	CN¥175.7m	0%	no data
3.17%	Nanjing Biotech and Pharmaceutical Valley Construction and Development Co., Ltd	12,962,804	CN¥175.4m	0%	no data
3.06%	Caitong Fund Management Co., Ltd.	12,505,909	CN¥169.2m	0%	0.98%
2.88%	Zhong Ou Fund Management Co., Ltd	11,756,580	CN¥159.1m	0%	0.08%
2.63%	E Fund Management Co., Ltd.	10,757,967	CN¥145.6m	0%	0.02%
2.4%	Zhoushan Liyan Enterprise Management Partnership Enterprise (Limited Partnership)	9,818,182	CN¥132.8m	0%	no data
2.32%	Nanjing Jiangbei New District State-owned Assets Management Co., Ltd.	9,459,405	CN¥128.0m	0%	no data
2.12%	China Universal Asset Management Company Ltd.	8,673,279	CN¥117.3m	0%	0.05%
2.01%	CDH Investment Management Company Limited	8,220,533	CN¥111.2m	0%	1.69%
1.41%	Shenzhen Gaoling Tiancheng Phase 3 Investment Co., Ltd.	5,764,485	CN¥78.0m	0%	7.36%
1.28%	Morgan Stanley (China) Private Equity Investment Management Co., Ltd.	5,228,013	CN¥70.7m	0%	8.39%
1.16%	National Council for Social Security Fund	4,735,841	CN¥64.1m	0%	0.01%
1.13%	Tianhong Asset Management Co., Ltd.	4,618,145	CN¥62.5m	0%	0.04%
1.04%	Shanghai Yaocui Investment Center (Limited Partnership)	4,264,809	CN¥57.7m	0%	no data
0.97%	Guochuang Zhongding (Shanghai) Equity Investment Management Co., Ltd.	3,973,288	CN¥53.8m	0%	no data
0.68%	Golden Trust SinoPac Fund Management Co., Ltd.	2,762,898	CN¥37.4m	0%	0.33%
0.63%	GemPharmatech Co., Ltd., ESOP	2,562,872	CN¥34.7m	0%	no data
0.58%	GF Fund Management Co., Ltd.	2,368,561	CN¥32.0m	0%	0.01%
0.51%	Northeast Securities Co., Ltd., Asset Management Arm	2,091,855	CN¥28.3m	0%	4.0%
0.41%	Shenzhen Zoomtrend Investment Management Co., Ltd.	1,694,219	CN¥22.9m	0%	63.79%
0.37%	Bank of Communications Schroder Fund Management Co., Ltd.	1,529,263	CN¥20.7m	0%	0.02%
0.37%	China Southern Asset Management Co., Ltd.	1,522,342	CN¥20.6m	0%	0.01%
0.29%	BOC International China Limited, Asset Management Arm	1,183,435	CN¥16.0m	0%	0.88%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 19:59
End of Day Share Price	2024/12/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GemPharmatech Co., Ltd. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhu Chen	Citic Securities Co., Ltd.
Kai Wang	Citic Securities Co., Ltd.
Xiao Wei Lin	Everbright Securities Co. Ltd.